Remember Me
Or use your Academic/Social account:


Or use your Academic/Social account:


You have just completed your registration at OpenAire.

Before you can login to the site, you will need to activate your account. An e-mail will be sent to you with the proper instructions.


Please note that this site is currently undergoing Beta testing.
Any new content you create is not guaranteed to be present to the final version of the site upon release.

Thank you for your patience,
OpenAire Dev Team.

Close This Message


Verify Password:
Verify E-mail:
*All Fields Are Required.
Please Verify You Are Human:
fbtwitterlinkedinvimeoflicker grey 14rssslideshare1
Yacqub-Usman, Kiren (2013)
Languages: English
Types: Doctoral thesis
Subjects: RM
The genesis and outgrowth of pituitary adenomas is consequent to the combined contributions of genetic and epigenetic aberrations. Although the relative contribution of each is not known it is likely that particular aberration may be common or particular to an adenoma subtype(s). The impact of subtype specific changes presents significant challenges for clinical management options. In this thesis the potential impact of epigenetic aberrations, that target the Dopamine D2 Receptor (D2R) and the cytokine, Bone Morphogenic Protein 4 (BMP-4) were investigated. In these cases their expression patterns are frequently comprised in a subtype-specific context. This thesis reports that in pituitary cell lines, reduced expression of D2R and that of BMP4 are associated with CpG island methylation and histone modifications indicative of gene silencing. In these cases, incubation of cells with epidrugs, designed to reverse epigenetic silencing, restores their expression.
  • The results below are discovered through our pilot algorithms. Let us know how we are doing!

    • 1. Haneen Al-Azzawi*, Kiren Yacqub-Usman*, Alan Richardson, Leo Hofland, Richard N Clayton, William E Farrell. Reversal of Endogenous Dopamine Receptor Silencing in Pituitary Cells Augments Receptor-Mediated Apoptosis. Endocrinology (2011) 152: (2) 364-373.
    • 2. Kiren Yacqub-Usman, Alan Richardson, Cuong V. Duong, Richard N Clayton, William E Farrell. The pituitary tumour epigenome: aberrations and prospects for targeted therapy. Nature Reviews Endocrinology (2012) 8:(8) 486-94
    • 3. Kiren Yacqub-Usman, Cuong V. Duong, Richard N Clayton, William E Farrell. Epigenomic Silencing of the BMP-4 Gene in Pituitary Adenomas: A Potential Target for EpidrugInduced re-expression. Endocrinology (2012) 153:(8) 3603-12
    • 4. Cuong V. Duong, Richard D Emes, Frank Wessely, Kiren Yacqub-Usman, Richard N Clayton, William E Farrell. Quantitative, genome-wide analysis of the DNA methylome in sporadic pituitary adenomas. Endocrine Related Cancer (2012) 19:1-12
    • 5. Kiren Yacqub-Usman, Cuong V. Duong, Richard N Clayton, William E Farrell. Preincubation of Pituitary Tumour Cells with the Epidrugs Zebularine and Trichostatin A are Permissive for Retinoic Acid Augmented Expression of the BMP-4 and D2R genes. Endocrinology (2013) 154:(5) 1711-21
  • No related research data.
  • No similar publications.

Share - Bookmark

Cite this article